State of Alaska Department of Revenue’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,797
| Closed | -$249K | – | 1628 |
|
|
2023
Q2 | $249K | Sell |
37,797
-1,088
| -3% | -$7.17K | ﹤0.01% | 1577 |
|
|
2023
Q1 | $264K | Sell |
38,885
-520
| -1% | -$3.53K | ﹤0.01% | 1569 |
|
|
2022
Q4 | $291K | Buy |
39,405
+246
| +0.6% | +$1.82K | ﹤0.01% | 1548 |
|
|
2022
Q3 | $386K | Sell |
39,159
-3,569
| -8% | -$35.2K | 0.01% | 1432 |
|
|
2022
Q2 | $465K | Buy |
42,728
+3,970
| +10% | +$43.2K | 0.01% | 1388 |
|
|
2022
Q1 | $438K | Sell |
38,758
-690
| -2% | -$7.8K | ﹤0.01% | 1444 |
|
|
2021
Q4 | $618K | Sell |
39,448
-1,140
| -3% | -$17.9K | 0.01% | 1345 |
|
|
2021
Q3 | $695K | Buy |
40,588
+2,145
| +6% | +$36.7K | 0.01% | 1298 |
|
|
2021
Q2 | $826K | Buy |
38,443
+1,287
| +3% | +$27.7K | 0.01% | 1183 |
|
|
2021
Q1 | $558K | Sell |
37,156
-5,410
| -13% | -$81.2K | 0.01% | 1379 |
|
|
2020
Q4 | $559K | Sell |
42,566
-8,570
| -17% | -$113K | 0.01% | 1302 |
|
|
2020
Q3 | $493K | Sell |
51,136
-30
| -0.1% | -$289 | 0.01% | 1244 |
|
|
2020
Q2 | $585K | Buy |
51,166
+1,690
| +3% | +$19.3K | 0.01% | 1162 |
|
|
2020
Q1 | $512K | Buy |
49,476
+9,200
| +23% | +$95.2K | 0.01% | 1092 |
|
|
2019
Q4 | $660K | Sell |
40,276
-590
| -1% | -$9.67K | 0.01% | 1161 |
|
|
2019
Q3 | $542K | Buy |
40,866
+22,836
| +127% | +$303K | 0.01% | 1228 |
|
|
2019
Q2 | $254K | Buy |
18,030
+288
| +2% | +$4.06K | ﹤0.01% | 1373 |
|
|
2019
Q1 | $326K | Buy |
17,742
+165
| +0.9% | +$3.03K | 0.01% | 1278 |
|
|
2018
Q4 | $459K | Buy |
17,577
+150
| +0.9% | +$3.92K | 0.01% | 1011 |
|
|
2018
Q3 | $399K | Buy |
+17,427
| New | +$399K | 0.01% | 1224 |
|